|Articles|June 26, 2011
Sulfonylurea monotherapy ups CVD risk vs. metformin in older diabetics
Older patients started on oral antidiabetic therapy with a sulfonylurea have significantly higher risk for cardiovascular disease (CVD) events than patients started on metformin.
Advertisement
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Medical Economics
1
Trump threatens to upend GLP-1 market with vow to slash Ozempic prices
2
Private practice is dying. Here's how to save it.
3
Barriers to physician mental health: What to do if you need help
4
KFF poll: 4 in 10 parents back Trump, RFK Jr.’s “MAHA” agenda
5